Quantcast

Latest Pioglitazone Stories

2014-03-27 08:34:15

Sub-analyses Investigate the Effects of alogliptin on Cardiovascular Mortality Rates and Hospitalization for Heart Failure in Type 2 Diabetes Patients with Recent Acute Coronary Syndrome WASHINGTON and OSAKA, Japan, March 27, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome)...

2014-03-23 23:01:51

An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March 23, 2014 Cancer Monthly is reporting on the results of an Italian Meta-Analysis involving more than 13,197 patients who had taken either the diabetes drug Actos or another thiazolidinedione called rosiglitazone. Researchers at the Careggi Teaching Hospital in Florence, Italy scoured the medical literature for both published and...

2014-03-21 23:22:34

An increased risk of bladder cancer may not be the only disease risk for people treated with the diabetes drug Actos. Raleigh, NC (PRWEB) March 21, 2014 Cancer Monthly is reporting on new research published by PLoS One suggesting that the diabetes drug Actos, which is already associated with an increased risk of bladder cancer, may also increase the risk of developing chronic kidney disease. Actos (pioglitazone) is in a class of drugs called thiazolidinediones and has been administered...

2014-03-18 23:30:30

Last week an Actos trial began in Clark County Courts - Eighth Circuit Court of Nevada where two plaintiffs allege that suffered bladder cancer from Actos. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Actos side effects. San Diego, CA (PRWEB) March 18, 2014 AttorneyOne.com, a recognized authority on law, updated the website recently and...

2014-03-10 23:00:32

A new study published in the British Journal of Clinical Pharmacology, recommends prescribers limit pioglitazone (Actos) use to shorter durations due to significantly increased risk of bladder cancer. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Actos side effects. San Diego, CA (PRWEB) March 10, 2014 AttorneyOne.com, a recognized...

2014-03-08 23:01:58

Another meta-analysis has confirmed an increased risk of bladder cancer among diabetes patients who have taken the drug Actos (pioglitazone). Raleigh, NC (PRWEB) March 08, 2014 Cancer Monthly is reporting on a published study that appears to be more bad news for the manufacturers of the once-popular diabetes drug, Actos. The drug, also known as pioglitazone, was designed to help with glycemic control, but multiple studies have shown a connection between Actos and bladder cancer. In a...

2014-03-05 23:28:42

National network of attorneys continues to provide no-cost consultations over allegations that the use of the diabetes medication Actos can cause bladder cancer. San Diego, Ca (PRWEB) March 05, 2014 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople today announced today there are new legal developments of interest to consumers following litigation* involving allegations that the use of Actos to treat diabetes can cause bladder cancer....

2014-03-05 23:25:20

Diabetic patients who develop bladder cancer after taking the drug Actos (pioglitazone) tend to have about the same number of Stage I, II, and III cancers as surgical patients who never used Actos. Raleigh, NC (PRWEB) March 05, 2014 A new published study of patients who had their bladders removed because of cancer suggests that the drug Actos may not have much effect on the growth and extent of cancer. As Cancer Monthly reports, the study, published in BMC Urology, examined the cases of...

2014-02-26 23:24:59

Research on more than 11,000 Korean users of the diabetes drug pioglitazone finds that smaller doses are no protection against bladder cancer. Raleigh, NC (PRWEB) February 26, 2014 A new article published in the Journal of Korean Medical Science and reported by Cancer Monthly finds that diabetics who have been treated with pioglitazone (Actos) for more than 6 months may still face a higher risk of bladder cancer, even if they were on a low dose. The retrospective study focused on more...

2014-02-19 23:24:56

Taiwanese author says his research should relieve concern among diabetics that insulin might raise their cancer risk. Raleigh, NC (PRWEB) February 19, 2014 Cancer Monthly is reporting on a recently-published meta-analysis of diabetes patients that appears to show no increased risk of bladder cancer as a result of using human insulin. The large-scale study analyzed the health insurance reimbursement databases of 785,234 type 2 diabetes patients from 1996 to 2009. In 2009, the entire...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related